Physician profile
Nancy A Jameson
NPI 1992770804
$5,494.90
in general payments reported to CMS, 2019-2025
24 companies · $386 in 2025
The $386 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,286 · 2020: $285 · 2021: $927 · 2022: $1,010 · 2023: $738 · 2024: $863 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,987.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,986.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,079.29 | 2019-2023 | Clareon |
| Genentech USA, INC. | $743.88 | 2019-2025 | Vabysmo |
| Johnson & Johnson Surgical Vision, INC. | $549.71 | 2021-2023 | Amo Phaco Needle |
| Sight Sciences, INC. | $425.49 | 2019-2022 | |
| Regeneron Healthcare Solutions, INC. | $370.51 | 2019-2025 | Eylea Hd, Eylea |
| Biotissue Holdings INC. | $284.65 | 2019-2023 | |
| Apellis Pharmaceuticals, INC. | $256.78 | 2024 | Syfovre |
| Microsurgical Technology, INC. | $241.68 | 2024 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $221.59 | 2019-2021 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $197.61 | 2024-2025 | |
| Allergan, INC. | $190.66 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $182.91 | 2019-2021 | |
| Amgen INC. | $172.90 | 2024-2025 | Tepezza |
| Abbvie INC. | $119.88 | 2023 | |
| Biogen, INC. | $116.13 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sandoz INC. | $91.09 | 2024 | Cimerli |
| Rxsight INC | $59.64 | 2021 | |
| Novartis Pharmaceuticals Corporation | $49.47 | 2019-2020 | |
| Oyster Point Pharma, INC. | $33.88 | 2023 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $24.13 | 2019 | |
| Dompe US, INC. | $22.53 | 2021 | |
| Bausch & Lomb Americas INC. | $20.92 | 2024 | Envista Mx60 Iol |
| Kala Pharmaceuticals, INC. | $20.17 | 2021 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Jameson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.